Yuriko Fukuta, MD, PhD, discusses her research team's study, which evaluated the risk factors associated with post-COVID conditions. She presented her findings at IDWeek 2023 in Boston, MA.
The FDA approved the use of Pfizer’s bivalent prefusion f vaccine in older adults to protect against respiratory syncytial virus. A Pfizer spokesperson answered questions about the study that helped lead to...
In this Q and A, otolaryngologist Eric Smouha, MD, answers our questions about the possible association between COVID-19 infection and audio-vestibular symptoms, including the effects of SARS-CoV-2 virus on...
As the number of new hepatitis C virus infections continues to rise in the United States, rapid diagnosis and treatment of high-risk patients is more important than ever. In this Q&A, Benjamin Eckhardt, MD,...
Comorbidities are a large part of the disease burden for people living with HIV. A recent study aimed to examine the prevalence of both high-risk and functional comorbidities in this patient population....
The continuation of proper care once a patient with sepsis is discharged from the hospital is critical in reducing the risk of rehospitalization and mortality. Stephanie Parks Taylor, MD, answers our...
As influenza vaccination rates among health care workers often fall at substandard levels, mandatory vaccination has been proposed. In this Q&A, Gianluca Voglino, MD, discusses his team’s findings on the...
A recent study sought to examine the risk factors for with weight gain in patients beginning antiretroviral therapy for the management of HIV. Lead author Moupali Das, MD, MPH, answered our questions in...
Davide De Francesco, from University College London, answers our questions about his study on whether people with HIV experience greater age advancement than patients without HIV.
Patients with psoriasis and HIV comprise a unique subgroup that requires special consideration for treatment due to complications and comorbidities associated with both diseases, according to Wilson Liao,...
